Acadia Healthcare to Participate in 44th Annual J.P. Morgan Healthcare Conference
ACHCFRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in the 44th Annual J.P. Morgan Healthcare Conference, January 12-15, 2026, in San Francisco, California. In connection with the conference, there will be an online webcast of the Company’s presentation available on the Company’s website starting at 5:15 p.m. Pacific Time/ 7:15 p.m. Central Time on Tuesday, January 13, 2026. The live webcast of the presentation will
Securities Fraud Investigation Into Acadia Healthcare Company, Inc. (ACHC) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
ACHCLOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) investors concerning the Company’s possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ACADIA HEALTHCARE COMPANY, INC. (ACHC), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.
Acadia Healthcare Company, Inc. (ACHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
ACHCBENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ACADIA HEALTHCARE COMPANY, INC. (ACHC), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss
Securities Fraud Investigation Into Acadia Healthcare Company, Inc. (ACHC) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
ACHCLOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ACADIA HEALTHCARE COMPANY, INC. (ACHC), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is the Investigation About? On December 2, 2025, after market hours, A
Acadia Healthcare Issues Statement Highlighting Commitment to Value Creation
ACHCFRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today issued the following statement: Our Board of Directors and management team are steadfast in our commitment to enhancing long-term shareholder value. We regularly communicate with our shareholders regarding our value creation plan and welcome constructive input as we move forward. At Acadia, our mission is to create a world-class organization that sets the standard of excellence in the treatment of behavioral
Engine Capital Sends Letter to Acadia Healthcare’s Board of Directors Regarding the Urgent Need for Strategy and Governance Changes
ACHCNEW YORK--(BUSINESS WIRE)--Engine Capital LP (together with its affiliates, “Engine” or “we”), which owns approximately 3% of the outstanding shares of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (“Acadia” or the “Company”), today sent a letter to the Company’s Board of Directors outlining opportunities to close Acadia’s significant valuation gap and unlock value for shareholders. The letter can be viewed and downloaded here. About Engine Capital Engine Capital LP is a value-oriented special
Acadia Healthcare Reports Second Quarter 2025 Results
ACHCFRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights Revenue totaled $869.2 million, an increase of 9.2% over the second quarter of 2024 Same facility revenue increased 9.5% compared with the second quarter of 2024, including an increase in revenue per patient day of 7.5% and an increase in patient days of 1.8% Net income attributab
Acadia Healthcare Investor Alert: Scott+Scott Attorneys at Law LLP Investigates Acadia Healthcare Company, Inc.’s Directors and Officers for Breach of Fiduciary Duties – ACHC
ACHCNEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the leadership of Acadia Healthcare Company, Inc. (“Acadia Healthcare”) (NASDAQ: ACHC) breached their fiduciary duties to Acadia Healthcare and its shareholders. CLICK HERE TO LEARN MORE Scott+Scott is investigating whether members of the Acadia Healthcare board of directors or senior management failed to manage Acadia Healthcare
Mizuho Maintains Neutral on Acadia Healthcare Co, Lowers Price Target to $32
ACHCBarclays Maintains Equal-Weight on Acadia Healthcare Co, Lowers Price Target to $28
ACHCKeybanc Maintains Overweight on Acadia Healthcare Co, Lowers Price Target to $55
ACHCUS Stocks Likely To Open Lower After A Strong Rally: 'Lows Are Likely In And Better Times Are Coming,' Says Expert
ACHCU.S. stock futures fell on Tuesday after a stellar rally on Monday. Futures of major benchmark indices were trading lower in premarket.
Under Armour, CyberArk Software And 3 Stocks To Watch Heading Into Tuesday
ACHCAcadia Healthcare Co Affirms FY2025 Adj EPS Guidance of $2.50-$2.80 vs $2.65 Est; Affirms FY2025 Sales Guidance of $3.30B-$3.40B vs $3.34B Est
ACHCAcadia Healthcare Co Q1 Adj. EPS $0.40 Beats $0.36 Estimate, Sales $770.50M Beat $769.84M Estimate
ACHCEarnings Scheduled For May 12, 2025
ACHCIs Acadia Healthcare Co Gaining or Losing Market Support?
ACHCGuggenheim Initiates Coverage On Acadia Healthcare Co with Buy Rating, Announces Price Target of $36
ACHC5 Stock Picks Last Month From Wall Street's Most Accurate Analysts
ACHC5 Stocks In The Spotlight From Wall Street's Most Accurate Analysts Last Week
ACHCForecasting The Future: 8 Analyst Projections For Acadia Healthcare Co
ACHCMizuho Maintains Neutral on Acadia Healthcare Co, Lowers Price Target to $37
ACHCHewlett Packard Enterprise Issues Weak Forecast, Joins Clarus, Samsara And Other Big Stocks Moving Lower In Friday's Pre-Market Session
ACHCAcadia Healthcare Plans $500M Debt Offering to Prepay Existing Credit Borrowings
ACHCRBC Capital Maintains Outperform on Acadia Healthcare Co, Lowers Price Target to $43
ACHCKeybanc Maintains Overweight on Acadia Healthcare Co, Lowers Price Target to $65
ACHCMarket Whales and Their Recent Bets on ACHC Options
ACHCBarclays Downgrades Acadia Healthcare Co to Equal-Weight, Lowers Price Target to $35
ACHCBeyond The Numbers: 6 Analysts Discuss Acadia Healthcare Co Stock
ACHCB of A Securities Maintains Buy on Acadia Healthcare Co, Lowers Price Target to $44.5
ACHCArcadia Healthcare Sees FY25 Adj. EPS $2.50-$2.80; Revenue $3.3B-$3.4B.
ACHCAcadia Healthcare Co Q4 2024 Adj. EPS $0.64 Misses $0.71 Estimate, Sales $774.238M Miss $778.988M Estimate
ACHCRBC Capital Reiterates Outperform on Acadia Healthcare Co, Maintains $64 Price Target
ACHCDecoding 5 Analyst Evaluations For Acadia Healthcare Co
ACHCRBC Capital Maintains Outperform on Acadia Healthcare Co, Lowers Price Target to $64
ACHCRBC Capital Reiterates Outperform on Acadia Healthcare Co, Maintains $94 Price Target
ACHCAssessing Acadia Healthcare Co: Insights From 12 Financial Analysts
ACHCTD Cowen Maintains Buy on Acadia Healthcare Co, Lowers Price Target to $91
ACHCSeelos Therapeutics Announces Participation Of Acadia Healthcare In The Registration Directed Study Of SLS-002 (Intranasal Racemic Ketamine) For Acute Suicidal Ideation And Behavior In Patients With Major Depressive Disorder
ACHCRecap: Acadia Healthcare Co Q1 Earnings
ACHCAcadia Healthcare Co (NASDAQ:ACHC) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Acadia Reaffirms FY22 Guidance; Sees Adj. EPS $2.85-$3.15 vs $2.97 Est., Sales $2.55B-$2.60B vs $2.58B Est.
ACHCAcadia Healthcare Co Q1 Adj. EPS $0.67 Beats $0.64 Estimate, Sales $616.70M Beat $606.48M Estimate
ACHC